News

Targeted Protein Degradation in Autoimmune Disease: PROTACs, Molecular Glues, and the Next Wave of Oral Therapies

Targeted protein degradation is moving beyond oncology and into autoimmune disease. Explore how PROTACs, molecular glues, and emerging degradation strategies are targeting difficult immune pathways—and the safety questions that remain.